Miguel Abboud to Middle Aged
This is a "connection" page, showing publications Miguel Abboud has written about Middle Aged.
Connection Strength
0.174
-
Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
Score: 0.041
-
Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
Score: 0.031
-
Bereaved parental evaluation of the quality of a palliative care program in Lebanon. Pediatr Blood Cancer. 2011 Aug; 57(2):310-6.
Score: 0.026
-
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021 04 01; 96(4):404-417.
Score: 0.013
-
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
Score: 0.012
-
Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region. Clin Neurol Neurosurg. 2019 07; 182:92-97.
Score: 0.011
-
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 12; 103(12):2008-2015.
Score: 0.011
-
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
Score: 0.009
-
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014 Jul; 89(7):709-13.
Score: 0.008
-
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
Score: 0.008
-
Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003; 4(6):410-2.
Score: 0.004
-
Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition? Am J Hum Genet. 1984 Sep; 36(5):1001-14.
Score: 0.001